Facebook Linkedin RSS Twitter Youtube
Home 2018

Hepatitis B virus

Gilead to Develop Hepatitis B Therapies Using Precision’s ARCUS Genome Editing Platform
News

Gilead to Develop Hepatitis B Therapies Using Precision’s ARCUS Genome Editing Platform

Regulus Axing 60% of Workforce, Pauses Patient Recruitment for Lead Program
Industry News

Regulus Axing 60% of Workforce, Pauses Patient Recruitment for Lead Program

Vical Halts Development of HSV-2 Vaccine after Phase II Failure
Drug Discovery

Vical Halts Development of HSV-2 Vaccine after Phase II Failure

Hepatitis B Genetic Evolution from Stone Age Uncovered
Infectious Diseases

Hepatitis B Genetic Evolution from Stone Age Uncovered

Highly Sensitive Detection of Hepatitis B Using ddPCR
Cancer

Highly Sensitive Detection of Hepatitis B Using ddPCR

J&J, Bavarian Nordic Expand Vaccine Collaboration to HIV, Hepatitis B
Drug Discovery

J&J, Bavarian Nordic Expand Vaccine Collaboration to HIV, Hepatitis B

OnCore Beefs Up Oral HBV Compound Portfolio with Enantigen Acquisition
Industry News

OnCore Beefs Up Oral HBV Compound Portfolio with Enantigen Acquisition

Medivir, Daewoong Discontinue HBV Drug Development
News

Medivir, Daewoong Discontinue HBV Drug Development

HBV Target Triggers Viral Replication and Apoptosis
Infectious Diseases

HBV Target Triggers Viral Replication and Apoptosis

OGT Awarded $3.6M for Next-Generation Sequencing
Industry News

OGT Awarded $3.6M for Next-Generation Sequencing

1234Page 2 of 4
Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.